source
- Alethio Therapeutics secures $90 million to develop treatments for rare blood cancersAlethio Therapeutics, a UK based biotechnology startup, announced it has raised $90 million in new financing. The capital will be used to advance its pipeline targeting myeloproliferative neoplasm…
- Novo Nordisk lifts 2026 profit outlook after Wegovy obesity pill beats forecastsNovo Nordisk announced on Wednesday that it is raising its full-year profit and sales guidance after the third-quarter results for its Wegovy obesity pill came in above analysts' expectations. The…